Sulfur signaling pathway in cardiovascular disease
Frontiers in Pharmacology · 24.11.2023 · 14
DOI: 10.3389/fphar.2023.1303465 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.11.2023. Verfasst von Yunjia Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin, China. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
Hydrogen sulfide (H 2 S) and sulfur dioxide (SO 2 ), recognized as endogenous sulfur-containing gas signaling molecules, were the third and fourth molecules to be identified subsequent to nitric oxide and carbon monoxide (CO), and exerted diverse biological effects on the cardiovascular system. However, the exact mechanisms underlying the actions of H 2 S and SO 2 have remained elusive until now. Recently, novel post-translational modifications known as S-sulfhydration and S-sulfenylation, induced by H 2 S and SO 2 respectively, have been proposed. These modifications involve the chemical alteration of specific cysteine residues in target proteins through S-sulfhydration and S-sulfenylation, respectively. H 2 S induced S-sulfhydrylation can have a significant impact on various cellular processes such as cell survival, apoptosis, cell proliferation, metabolism, mitochondrial function, endoplasmic reticulum stress, vasodilation, anti-inflammatory response and oxidative stress in the cardiovascular system. Alternatively, S-sulfenylation caused by SO 2 serves primarily to maintain vascular homeostasis. Additional research is warranted to explore the physiological function of proteins with specific cysteine sites, despite the considerable advancements in comprehending the role of H 2 S-induced S-sulfhydration and SO 2 -induced S-sulfenylation in the cardiovascular system. The primary objective of this review is to present a comprehensive examination of the function and potential mechanism of S-sulfhydration and S-sulfenylation in the cardiovascular system. Proteins that undergo S-sulfhydration and S-sulfenylation may serve as promising targets for therapeutic intervention and drug development in the cardiovascular system. This could potentially expedite the future development and utilization of drugs related to H 2 S and SO 2 .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin, China.
- Department of Typhoid, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin, China.
- Department of Pediatrics, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Heilongjiang Province
- Postdoctoral Scientific Research Development Fund of Heilongjiang Province
Zitieren
APA
Song, Y., Xu, Z., Zhong, Q., Zhang, R., Sun, X., & Chen, G. (2023). Sulfur signaling pathway in cardiovascular disease. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1303465
Vancouver
Song Y, Xu Z, Zhong Q, Zhang R, Sun X, Chen G. Sulfur signaling pathway in cardiovascular disease. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1303465
BibTeX
@article{Song2023,
author = {Song, Yunjia and Xu, Zihang and Zhong, Qing and Zhang, Rong and Sun, Xutao and Chen, Guozhen},
title = {Sulfur signaling pathway in cardiovascular disease},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1303465}
}
EUVIMED